Brought to you by 
Shanghai Fosun buys 65% stake in Suzhou Eyre
21 Sep 2020
Executive Summary
Shanghai Fosun Pharmaceutical Group Co. Ltd. is paying $137.7mm for an initial 65% stake in private firm Suzhou Erye Pharmaceutical Co. Ltd. (generics for infectious and gastrointestinal diseases).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Acquisition
- Partial Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Shanghai Fosun buys 65% stake in Suzhou Eyre
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice